Cargando…

Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma

Detalles Bibliográficos
Autor principal: Longevity, Oxidative Medicine and Cellular
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412217/
https://www.ncbi.nlm.nih.gov/pubmed/37565158
http://dx.doi.org/10.1155/2023/9806284
_version_ 1785086843826470912
author Longevity, Oxidative Medicine and Cellular
author_facet Longevity, Oxidative Medicine and Cellular
author_sort Longevity, Oxidative Medicine and Cellular
collection PubMed
description
format Online
Article
Text
id pubmed-10412217
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-104122172023-08-10 Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma Longevity, Oxidative Medicine and Cellular Oxid Med Cell Longev Retraction Hindawi 2023-08-02 /pmc/articles/PMC10412217/ /pubmed/37565158 http://dx.doi.org/10.1155/2023/9806284 Text en Copyright © 2023 Oxidative Medicine and Cellular Longevity. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Longevity, Oxidative Medicine and Cellular
Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma
title Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma
title_full Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma
title_fullStr Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma
title_full_unstemmed Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma
title_short Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma
title_sort retracted: cdc20 may serve as a potential biomarker-based risk score system in predicting the prognosis of patients with hepatocellular carcinoma
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412217/
https://www.ncbi.nlm.nih.gov/pubmed/37565158
http://dx.doi.org/10.1155/2023/9806284
work_keys_str_mv AT longevityoxidativemedicineandcellular retractedcdc20mayserveasapotentialbiomarkerbasedriskscoresysteminpredictingtheprognosisofpatientswithhepatocellularcarcinoma